Champions Oncology Inc.

NASDAQ: CSBR · Real-Time Price · USD
6.53
0.01 (0.15%)
At close: Aug 15, 2025, 3:59 PM
6.52
-0.15%
After-hours: Aug 15, 2025, 04:00 PM EDT

Champions Oncology Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
Revenue
n/a 50.16M 53.87M 49.11M 41.04M
Cost of Revenue
28.39M 29.4M 29.53M 23.63M 21.47M
Gross Profit
-28.39M 20.75M 24.34M 25.48M 19.57M
Operating Income
4.55M -7.36M -4.45M 607K 338K
Interest Income
n/a n/a n/a n/a n/a
Pretax Income
4.63M -7.31M -5.27M 583K 409K
Net Income
4.7M -7.28M -5.33M 548K 362K
Selling & General & Admin
16.88M 18.13M 17.24M 15.5M 12.03M
Research & Development
6.83M 9.54M 11.54M 9.37M 7.2M
Other Expenses
293K 435K -11K -24K 71K
Operating Expenses
24M 28.11M 28.79M 24.87M 19.23M
Interest Expense
n/a n/a n/a 24K n/a
Selling & Marketing Expenses
7.54M 7.06M 7M 6.38M 5.52M
Cost & Expenses
52.39M 57.51M 58.32M 48.5M 40.7M
Income Tax Expense
-75K -32K 68K 35K 75K
Shares Outstanding (Basic)
13.66M 13.55M 13.54M 13.2M 13.14M
Shares Outstanding (Diluted)
14.27M 13.55M 13.54M 14.16M 14.57M
EPS (Basic)
0.34 -0.54 -0.39 0.04 0.03
EPS (Diluted)
0.33 -0.54 -0.39 0.04 0.02
EBITDA
4.55M -5.05M -2.07M 2.23M 366K
EBIT
n/a -6.92M -4.45M 583K 437K
Depreciation & Amortization
n/a 1.87M 3.2M 2.41M 1.58M